Vicore Pharma Holding
19.24 SEK +1.91%1 investor is following this company
Vicore Pharma Holding is a pharmaceutical company. The company conducts research and development of molecules with agnostic effect, in industry terms called Renin-Angiotensin System (RAS), which affects the fluid and salt balance in the body. Vicore Pharma usually enters into licensing agreements with other pharmaceutical partners in the industry and has business operations at a global level. The company was founded in 2000 and is headquartered in Gothenburg.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VICO
Daily low / high price
18.98 / 20.05
SEK
Market cap
2.15B SEK
Turnover
7.89M SEK
Volume
403K
Latest videos
Financial calendar
Interim report
03.05.2024
General meeting
07.05.2024
Interim report
22.08.2024
Interim report
05.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
HealthCap VII L.P. | 16.5 % | 16.5 % |
Fjärde AP-fonden | 9.8 % | 9.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vicore to Present at Upcoming Investor Conferences
Notice of annual general meeting of Vicore Pharma Holding AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools